158 related articles for article (PubMed ID: 31921616)
1. Silencing of Long Non-coding RNA SMAD5-AS1 Reverses Epithelial Mesenchymal Transition in Nasopharyngeal Carcinoma via microRNA-195-Dependent Inhibition of SMAD5.
Li S; Zhao B; Zhao H; Shang C; Zhang M; Xiong X; Pu J; Kuang B; Deng G
Front Oncol; 2019; 9():1246. PubMed ID: 31921616
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA SMAD5-AS1 acts as a microRNA-106a-5p sponge to promote epithelial mesenchymal transition in nasopharyngeal carcinoma.
Zheng YJ; Zhao JY; Liang TS; Wang P; Wang J; Yang DK; Liu ZS
FASEB J; 2019 Nov; 33(11):12915-12928. PubMed ID: 31557058
[TBL] [Abstract][Full Text] [Related]
3. LncRNA TP73-AS1 regulates miR-495 expression to promote migration and invasion of nasopharyngeal carcinoma cells through junctional adhesion molecule A.
Dai BQ; Jiang X; Feng LC
Kaohsiung J Med Sci; 2021 May; 37(5):361-370. PubMed ID: 33400379
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA ROR1-AS1 induces tumor metastasis and epithelial-mesenchymal transition by sponging miR-375 in nasopharyngeal carcinoma.
Hou J; Yan J; Ren XY; Zhu K; Du XY; Li JJ; Xu M
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):174-180. PubMed ID: 31957830
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MSC-AS1 aggravates nasopharyngeal carcinoma progression by targeting miR-524-5p/nuclear receptor subfamily 4 group A member 2 (NR4A2).
Yao H; Yang L; Tian L; Guo Y; Li Y
Cancer Cell Int; 2020; 20():138. PubMed ID: 32368184
[TBL] [Abstract][Full Text] [Related]
6. LncRNA
Chen X; Huang Y; Shi D; Nie C; Luo Y; Guo L; Zou Y; Xie C
Onco Targets Ther; 2020; 13():4397-4409. PubMed ID: 32606725
[TBL] [Abstract][Full Text] [Related]
7. LncRNA FOXP4-AS1 silencing inhibits metastasis and epithelial-mesenchymal transition in nasopharyngeal carcinoma via miR-136-5p/MAPK1.
Yan J; Zhou Q
Anticancer Drugs; 2023 Nov; 34(10):1104-1111. PubMed ID: 36961080
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA AFAP1-AS1 acts as a competing endogenous RNA of miR-423-5p to facilitate nasopharyngeal carcinoma metastasis through regulating the Rho/Rac pathway.
Lian Y; Xiong F; Yang L; Bo H; Gong Z; Wang Y; Wei F; Tang Y; Li X; Liao Q; Wang H; Zhou M; Xiang B; Wu X; Li Y; Li X; Chen X; Li G; Guo C; Zeng Z; Xiong W
J Exp Clin Cancer Res; 2018 Oct; 37(1):253. PubMed ID: 30326930
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of long non-coding RNA TUG1 suppresses nasopharyngeal carcinoma progression by inhibiting epithelial-mesenchymal transition (EMT) via the promotion of miR-384.
Qian W; Ren Z; Lu X
Biochem Biophys Res Commun; 2019 Jan; 509(1):56-63. PubMed ID: 30581000
[TBL] [Abstract][Full Text] [Related]
10. KIF9-AS1 promotes nasopharyngeal carcinoma progression by suppressing miR-16.
You H; Wang S; Yu S
Oncol Lett; 2020 Nov; 20(5):241. PubMed ID: 32973955
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA FOXD2-AS1 aggravates nasopharyngeal carcinoma carcinogenesis by modulating miR-363-5p/S100A1 pathway.
Chen G; Sun W; Hua X; Zeng W; Yang L
Gene; 2018 Mar; 645():76-84. PubMed ID: 29248577
[TBL] [Abstract][Full Text] [Related]
12. TMPO-AS1 Regulates the Aggressiveness-Associated Traits of Nasopharyngeal Carcinoma Cells Through Sponging miR-320a.
Xing B; Qiao XF; Qiu YH; Li X
Cancer Manag Res; 2021; 13():415-425. PubMed ID: 33488123
[TBL] [Abstract][Full Text] [Related]
13. ZNRD1-AS1 Promotes Nasopharyngeal Carcinoma Cell Invasion and Metastasis by Regulating the miR-335-ROCK1 Axis.
Wang Q; Hu X; Du M; Lu Z; Yan K; Zhao D; Jiang N; Peng Y; He X; Yin L
Onco Targets Ther; 2020; 13():4779-4790. PubMed ID: 32547105
[TBL] [Abstract][Full Text] [Related]
14. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
[TBL] [Abstract][Full Text] [Related]
15. TTN-AS1 accelerates the growth and migration of nasopharyngeal carcinoma cells via targeting miR-876-5p/NETO2.
Chen X; Xu W; Ma Z; Zhu J; Hu J; Li X; Fu S
Mol Ther Oncolytics; 2022 Mar; 24():535-546. PubMed ID: 35229031
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-384 inhibits nasopharyngeal carcinoma growth and metastasis via binding to Smad5 and suppressing the Wnt/β-catenin axis.
Zeng X; Liao H; Wang F
Cytotechnology; 2021 Apr; 73(2):203-215. PubMed ID: 33911345
[TBL] [Abstract][Full Text] [Related]
17. MiR-34a Inhibits Cell Proliferation and Induces Apoptosis in Human Nasopharyngeal Carcinoma by Targeting lncRNA MCM3AP-AS1.
Sun P; Feng Y; Guo H; Li R; Yu P; Zhou X; Pan Z; Liang Y; Yu B; Zheng Y; Shi Y; Wen L; Wei M; Chen Y
Cancer Manag Res; 2020; 12():4799-4806. PubMed ID: 32606969
[TBL] [Abstract][Full Text] [Related]
18. LncRNA IGBP1-AS1 targets miR-150-5p to increase ZEB1 expression in nasopharyngeal carcinoma.
Wang LJ; Wang YS; Zhao Y
Transl Cancer Res; 2022 Mar; 11(3):530-537. PubMed ID: 35402187
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of lncRNA NCK1-AS1 Inhibits Cancer Cell Migration and Invasion in Nasopharyngeal Carcinoma by Upregulating miR-135a.
Hu H; Li H; Feng X
Cancer Manag Res; 2019; 11():10531-10537. PubMed ID: 31908525
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA HOXD-AS1 induces epithelial-mesenchymal transition in breast cancer by acting as a competing endogenous RNA of miR-421.
Li Y; Han X; Li Q; Wang C; Lou Z; Wang X
J Cell Biochem; 2019 Jun; 120(6):10633-10642. PubMed ID: 30730081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
